A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (babilon trial): 24-month clinical and angiographic results

EuroIntervention

Volumn 10, Issue 1, 2014, Pages 50-57

  Mínguez, José Ramón López ^a   Asensio, Juan Manuel Nogales ^a   Vecino, Luis Javier Doncel ^a   Sandoval, Jorge ^b   Romany, Sebastián ^c   Romero, Pedro Martínez ^d   Díaz, José Antonio Fernández ^e   Portales, Javier Fernández ^c   Fernández, Reyes González ^a   Cáceres, Ginés Martínez ^a   Herrera, Antonio Merchán ^a   Manterola, Fernando Alfonso ^b  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^d HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Bifurcation lesions; Drug coated balloon; Drug eluting balloon; Drug eluting stent

Indexed keywords

EVEROLIMUS; PACLITAXEL; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TICLOPIDINE; TUBULIN MODULATOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; BARE METAL STENT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY RECANALIZATION; CORONARY BIFURCATION LESION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY; ANALOGS AND DERIVATIVES; ANGINA PECTORIS; CLINICAL TRIAL; COMPLICATION; CORONARY RESTENOSIS; CORONARY STENOSIS; MIDDLE AGED; PROCEDURES; STENT; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; SIROLIMUS; STENTS; TICLOPIDINE; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 84902305799     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I1A10     Document Type: Article

References (25)

1. Zhang F, Dong L, Ge J. Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials. Heart. 2009;95:1676-81.
2. Medina A, Suarez de Lezo J, Pan M. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59:183.
3. Zimarino M, Corazzini A, Ricci F, Di Nicola M, De Caterina R. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies. JACC Cardiovasc Interv. 2013;6:687-95.
4. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810-4.
5. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381:461-7.
6. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Menozzi A. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol. 2012;60:2473-80.
7. Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, Limbruno U. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart. 2010;96:1291-6.
8. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention. 2011;7:K61-5.
9. Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv. 2012;80:1138-46.
10. Kleber FX, Mathey DG, Rittger H, Scheller B. How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention. 2011;7:K125-8.
11. Finet G, Gilard M, Perrenot B, Rioufol G, Motreff P, Gavit L, Prost R. Fractal geometry of arterial coronary bifurcations: a quantitative coronary angiography and intravascular ultrasound analysis. EuroIntervention. 2008;3:490-8.
12. Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1193-200.
13. Hamm C, Cremers B, Moellmann H, Mobius-Winkler S, Zeymer U, Vrolix M, Schneider S, Dietz U, Bohm M, Scheller B. PEPCAD III: a randomised trial comparing a paclitaxel-coated balloon/stent system with a sirolimus eluting stent. (Included in: Late-Breaking Clinical Trial/Science Abstracts From the American Heart Association's Scientific Sessions 2009). Circulation. 2009;120:2157.
14. Liistro F, Porto I, Angioli P, Grotti S, Ducci K, Falsini G, Bolognese L. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial. Am Heart J. 2013;166:920-6.
15. Ali RM, Degenhardt R, Zambahari R, Tresukosol D, Ahmad WA, Kamar H, Kui-Hian S, Ong TK, bin Ismail O, bin Elis S, Udychalerm W, Ackermann H, Boxberger M, Unverdorben M. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention. 2011;7:K83-92.
16. Radke PW, Joner M, Joost A, Byrne RA, Hartwig S, Bayer G, Steigerwald K, Wittchow E. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. EuroIntervention. 2011;7:730-7.
17. Bondesson P, Lagerqvist B, James SK, Olivecrona GK, Venetsanos D, Harnek J. Comparison of two drug-eluting balloons: a report from the SCAAR registry. EuroIntervention. 2012;8:444-9.
18. Cassese S, Kastrati A. Not all drug-eluting balloons are equally good for patients, not all patients are equally suitable for drug-eluting balloons. EuroIntervention. 2012;8:417-21.
19. Zhang T, Sun S, Shen L, He B. Drug-eluting balloons for de novo coronary artery disease: a meta-analysis of angiographic and clinical data. Catheter Cardiovasc Interv. 2013;82:1021-30.
20. Fischer D, Scheller B, Schafer A, Klein G, Bohm M, Clever Y, Cremers B. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. EuroIntervention. 2012;8:450-5.
21. Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T, Politi L, Doevendans PA, Sangiorgi GM, Stella PR. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol. 2012;59:2327-37.
22. Gutierrez-Chico JL, van Geuns RJ, Koch KT, Koolen JJ, Duckers H, Regar E, Serruys PW. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention. 2011;7:711-22.
23. Medina A, Martin P, Suarez de Lezo J, Novoa J, Melian F, Hernandez E, Suarez de Lezo J, Pan M, Burgos L, Amador C, Morera O, Garcia A. Ultrasound study of the prevalence of plaque at the carina in lesions that affect the coronary bifurcation. Implications for treatment with provisional stent. Rev Esp Cardiol. 2011;64:43-50.
24. Xu J, Hahn JY, Song YB, Choi SH, Choi JH, Lu C, Lee SH, Hong KP, Park JE, Gwon HC. Carina shift versus plaque shift for aggravation of side branch ostial stenosis in bifurcation lesions: volumetric intravascular ultrasound analysis of both branches. Circ Cardiovasc Interv. 2012;5:657-62.
25. Foin N, Torii R, Mortier P, De Beule M, Viceconte N, Chan PH, Davies JE, Xu XY, Krams R, Di Mario C. Kissing balloon or sequential dilation of the side branch and main vessel for provisional stenting of bifurcations: lessons from micro-computed tomography and computational simulations. JACC Cardiovasc Interv. 2012;5:47-56.